ArticleFrontiers in immunology2026

A CD40-targeting peptide, OPT501, modulates inflammation in canine diabetes mellitus improving clinical outcomes.

Gisela M Vaitaitis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.